| 前收盘价格 | 8.94 |
| 收盘价格 | 8.94 |
| 成交量 | 15,328 |
| 平均成交量 (3个月) | 1,058,535 |
| 市值 | 7,987,541 |
| 价格/销量 (P/S) | 523.83 |
| 股市价格/股市净资产 (P/B) | 1.07 |
| 52周波幅 | |
| 利润日期 | 30 Mar 2026 |
| 营业毛利率 | 3,711.54% |
| 营业利益率 (TTM) | -68,075.00% |
| 稀释每股收益 (EPS TTM) | 3.46 |
| 季度收入增长率 (YOY) | -99.20% |
| 总债务/股东权益 (D/E MRQ) | 22.57% |
| 流动比率 (MRQ) | 0.370 |
| 营业现金流 (OCF TTM) | -22.03 M |
| 杠杆自由现金流 (LFCF TTM) | -19.74 M |
| 资产报酬率 (ROA TTM) | -49.81% |
| 股东权益报酬率 (ROE TTM) | 644.12% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | PAVmed Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-0.4
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.38 |
|
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 22.22% |
| 机构持股比例 | 7.05% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Byrne Asset Management Llc | 31 Dec 2025 | 126,400 |
| First Manhattan Co. Llc. | 31 Dec 2025 | 23,801 |
| Xml Financial, Llc | 31 Dec 2025 | 336 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合